COMMUNIQUÉS West-GlobeNewswire

Tarsus to Participate in Upcoming Investor Conferences
29/05/2024
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
29/05/2024
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/2024
REDWOOD CITY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) [...]
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
29/05/2024
Webcast to include interim hematological results from at least 15 trial participants and feature experts in the treatment of chronic neutropenia BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR [...]
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
29/05/2024
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global [...]
L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024
29/05/2024
NEW YORK, 29 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome TALEN® pour développer [...]
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
29/05/2024
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024
29/05/2024
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2024
MARKHAM, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Certara to Participate in the Jefferies Global Healthcare Conference
29/05/2024
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference. [...]
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
29/05/2024
Nes-Ziona, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the closing of its previously [...]
Participation de Merus à un échange informel à l’occasion de la conférence Jefferies Global Healthcare
29/05/2024
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 29 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps pleine longueur multispécifiques et [...]
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
29/05/2024
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients [...]
GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
29/05/2024
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), 29 mai 2024 - GENFIT (Nasdaq et Euronext : GNFT) , une société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
29/05/2024
BOULDER, Colo., May 29, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small [...]
Immuneering to Present at the Jefferies Global Healthcare Conference
29/05/2024
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of [...]
Cardiff Oncology to Present at the Jefferies Healthcare Conference
29/05/2024
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced [...]
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
29/05/2024
SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
29/05/2024
QIAseq Multimodal DNA/RNA Lib Kit enables streamlined DNA and RNA library preparation for next-generation sequencing from a single sample // New kit advances precision medicine by facilitating multiomic studies and [...]

Pages